April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.
As pharmaceutical production methods continue to evolve, flow chemistry is emerging as a safer, more scalable and selective alternative to conventional batch manufacturing.
As discovery accelerates and throughput rises, digital transformation is becoming essential for chemistry labs. AI, robotics, and data growth must be orchestrated to boost productivity—rather than overwhelm the lab.
Newsletter & e-edition
News, trends and background information as well as the latest issue of CHEManager International
Many thanks for you registration!
Expert Insights
Comprehensive Insights into Antibody–Drug Conjugates
Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.
April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.
CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.
The Pharma Partnering Summit (PPS US) 2026 is set to return to San Diego, California, uniting senior business development and licensing (BD&L) professionals from the pharmaceutical and biotechnology sectors.
Since 2021, the Swiss Biotech Day has become a premier global biotechnology conference for life sciences professionals, fostering international collaboration and impactful partnerships.
This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
